198 related articles for article (PubMed ID: 15225700)
1. Synthesis and structure-activity relationships of 1,5-diazaanthraquinones as antitumour compounds.
Avendaño C; Pérez JM; Blanco Mdel M; de la Fuente JA; Manzanaro S; Vicent MJ; Martín MJ; Salvador-Tormo N; Menéndez JC
Bioorg Med Chem Lett; 2004 Aug; 14(15):3929-32. PubMed ID: 15225700
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and biological evaluation of new 1,5-diazaanthraquinones with cytotoxic activity.
Manzanaro S; Vicent MJ; Martín MJ; Salvador-Tormo N; Pérez JM; del Mar Blanco M; Avendaño C; Menéndez JC; de la Fuente JA
Bioorg Med Chem; 2004 Dec; 12(24):6505-15. PubMed ID: 15556767
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and in vitro cytotoxicity of 3-substituted-1,8-diazaanthraquinones produced by Lewis-acid catalyzed hetero Diels-Alder reaction.
Lee H; Lee SI; Yang SI
Bioorg Med Chem Lett; 1998 Nov; 8(21):2991-4. PubMed ID: 9873661
[TBL] [Abstract][Full Text] [Related]
4. Hypoxia activated prodrugs of a 9-aza-anthrapyrazole derivative that has promising anticancer activity.
El-Dakdouki MH; Adamski N; Foster L; Hacker MP; Erhardt PW
J Med Chem; 2011 Dec; 54(23):8224-7. PubMed ID: 22011244
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and structure-activity correlations of the cytotoxic bifunctional 1,4-diamidoanthraquinone derivatives.
Huang HS; Chiu HF; Lee AL; Guo CL; Yuan CL
Bioorg Med Chem; 2004 Dec; 12(23):6163-70. PubMed ID: 15519160
[TBL] [Abstract][Full Text] [Related]
6. Cyclopent[a]anthraquinones as DNA intercalating agents with covalent bond formation potential: synthesis and biological activity.
Kim JY; Su TL; Chou TC; Koehler B; Scarborough A; Ouerfelli O; Watanabe KA
J Med Chem; 1996 Jul; 39(14):2812-8. PubMed ID: 8709111
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and in vitro cytotoxic activity of aza- and diazaanthraquinone derivatives.
Nebois P; do Nascimento SC; Boitard M; Bartoli MH; Fillion H
Pharmazie; 1994 Nov; 49(11):819-21. PubMed ID: 7838868
[TBL] [Abstract][Full Text] [Related]
8. Regioselective synthesis and in vitro anticancer activity of 4-aza-podophyllotoxin derivatives catalyzed by L-proline.
Shi C; Wang J; Chen H; Shi D
J Comb Chem; 2010 Jul; 12(4):430-4. PubMed ID: 20503973
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and in-vitro cytotoxicity evaluation of novel naphtindolizinedione derivatives, part II: improved activity for aza-analogues.
Defant A; Guella G; Mancini I
Arch Pharm (Weinheim); 2009 Feb; 342(2):80-6. PubMed ID: 19173337
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, biological activity, and quantitative structure-activity relationship study of azanaphthalimide and arylnaphthalimide derivatives.
Braña MF; Gradillas A; Gómez A; Acero N; Llinares F; Muñoz-Mingarro D; Abradelo C; Rey-Stolle F; Yuste M; Campos J; Gallo MA; Espinosa A
J Med Chem; 2004 Apr; 47(9):2236-42. PubMed ID: 15084122
[TBL] [Abstract][Full Text] [Related]
11. Synthesis of N-substituted derivatives of 8,11-dimethyl-3,5-dioxo-4-azatricyclo[5.2.2.0(2,6)]undec-8-en-1-yl acetate and screening of cytotoxic activity of selected azatricycloundecane compounds.
Kossakowski J; Kuran B
Acta Pol Pharm; 2008; 65(3):371-5. PubMed ID: 18646557
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, DNA binding, and cytotoxicity studies of pyrrolo[2,1-c][1,4]benzodiazepine-anthraquinone conjugates.
Kamal A; Ramu R; Tekumalla V; Khanna GB; Barkume MS; Juvekar AS; Zingde SM
Bioorg Med Chem; 2007 Nov; 15(22):6868-75. PubMed ID: 17822905
[TBL] [Abstract][Full Text] [Related]
13. 1,4- and 2,6-disubstituted amidoanthracene-9,10-dione derivatives as inhibitors of human telomerase.
Perry PJ; Gowan SM; Reszka AP; Polucci P; Jenkins TC; Kelland LR; Neidle S
J Med Chem; 1998 Aug; 41(17):3253-60. PubMed ID: 9703471
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis and cytotoxic effect of hydroxy- and 3-alkylaminopropoxy-9,10-anthraquinone derivatives.
Teng CH; Won SJ; Lin CN
Bioorg Med Chem; 2005 May; 13(10):3439-45. PubMed ID: 15848756
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, human telomerase inhibition and anti-proliferative studies of a series of 2,7-bis-substituted amido-anthraquinone derivatives.
Huang HS; Huang KF; Li CL; Huang YY; Chiang YH; Huang FC; Lin JJ
Bioorg Med Chem; 2008 Jul; 16(14):6976-86. PubMed ID: 18571928
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and antitumor activity of 6- and 2-(1-substituted-thio-4-methylpent-3-enyl)-5,8-dimethoxynaphthalene-1,4-diones.
Zhao LM; Xie TP; He YQ; Xu DF; Li SS
Eur J Med Chem; 2009 Apr; 44(4):1410-4. PubMed ID: 18996624
[TBL] [Abstract][Full Text] [Related]
17. Synthesis of novel DNA cross-linking antitumour agents based on polyazamacrocycles.
Parker LL; Anderson FM; O'Hare CC; Lacy SM; Bingham JP; Robins DJ; Hartley JA
Bioorg Med Chem; 2005 Apr; 13(7):2389-95. PubMed ID: 15755641
[TBL] [Abstract][Full Text] [Related]
18. Development of cobalt(3,4-diarylsalen) complexes as tumor therapeutics.
Gust R; Ott I; Posselt D; Sommer K
J Med Chem; 2004 Nov; 47(24):5837-46. PubMed ID: 15537341
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis and biological evaluation of novel, simplified analogues of laulimalide: modification of the side chain.
Paterson I; Menche D; Håkansson AE; Longstaff A; Wong D; Barasoain I; Buey RM; Díaz JF
Bioorg Med Chem Lett; 2005 May; 15(9):2243-7. PubMed ID: 15837302
[TBL] [Abstract][Full Text] [Related]
20. Anticancer thiopyrano[2,3-d][1,3]thiazol-2-ones with norbornane moiety. Synthesis, cytotoxicity, physico-chemical properties, and computational studies.
Lesyk R; Zimenkovsky B; Atamanyuk D; Jensen F; Kieć-Kononowicz K; Gzella A
Bioorg Med Chem; 2006 Aug; 14(15):5230-40. PubMed ID: 16632367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
